UK's Ergomed expands pharmacovigilance business operations in Japan

Ergomed plc, a company focused on providing specialised services to the pharmaceutical industry, announces that its Prim...

April 26, 2021 | Monday | News
China's Hua Medicine brings novel drug for diabetes treatment

Hua Medicine has announced the first innovative diabetes drug Dozaglietin (The NDA application submitted by dorzagliatin...

April 26, 2021 | Monday | News
Korea establishes methods for safe cardio pharmacology

The Ministry of Food and Drug Safety (MFDS) in Korea has published a guidance on cardiovascular safety pharmacology eval...

April 22, 2021 | Thursday | News
Asahi Kasei Medical Bioprocess affiliate opens in China

Asahi Kasei Medical announces that an affiliated company in China, Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC), s...

April 21, 2021 | Wednesday | News
PTT, Lotus Pharma explore opportunities in South East Asia pharma markets

Lotus Pharmaceutical Co., Ltd., an Alvogen company, has announced the issuance of new shares through private placement t...

April 20, 2021 | Tuesday | News
SciNeuro Pharma, Eli Lilly accelerate antibody therapies in Greater China

SciNeuro Pharmaceuticals, an innovative biopharmaceutical company focused on delivering transformative therapies to pati...

April 19, 2021 | Monday | News
AbbVie and Pfizer lead rheumatoid arthritis digital marketing space in Australia

Rheumatoid arthritis (RA) treatment landscape in Australia is well established with several novel disease-modifying anti...

April 16, 2021 | Friday | Analysis
Korean firm introduces new botulinum toxin for aesthetic market

Aquavit Holdings LLC, with its manufacturing partner is Huons Bio Pharma, has announced that it acquired an exclusi...

April 15, 2021 | Thursday | News
Japanese NHI price listing triggers $15 M milestone payment to BioCryst

US based BioCryst Pharmaceuticals, Inc. has announced that the Japanese National Health Insurance System (NHI) has appro...

April 15, 2021 | Thursday | News
GSK Australia receives provisional nod for COVID-19 mAb treatment

The Therapeutic Goods Administration (TGA), part of the Department of Health in Australia, has granted a provisiona...

April 15, 2021 | Thursday | News
Bostik launches smart blister packaging solution for the pharma products

Bostik, a leading global adhesive specialist for industrial, construction and consumer markets, has launched HERBERTS&tr...

April 14, 2021 | Wednesday | News
Third-party ingredient verification key for drug supply chain

The last few decades have been defined by a series of disruptions to the global drug supply chain, and the industry cont...

April 13, 2021 | Tuesday | Opinion
An Asia-Pacific perspective on resilience in the biopharma industry

  Countries in Asia-Pacific may have fared well in comparison to those in other areas of the world in coping with ...

April 13, 2021 | Tuesday | Analysis
HEC Pharm increases biopharmaceutical production capacity in China

ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, has announced that it ...

April 12, 2021 | Monday | News
Varonis releases 2021 report on Healthcare Data Risk

Varonis, a global pioneer in data security based in the US, has just released its 2021 Healthcare Data Risk Report,...

April 7, 2021 | Wednesday | News
China and India... to play a vital role in supplying COVID-19 vaccines globally

1. What are the other contributions Avantor is making to fight this pandemic, particularly in APAC?     Our...

April 7, 2021 | Wednesday | Influencers
Global infrastructure and supply chain will need to improve

What are the current challenges facing the vaccine industry worldwide? The emergence of COVID-19 has caused a rapid...

April 7, 2021 | Wednesday | Influencers
Karo Pharma acquires brand portfolio from Teva Pharmaceuticals

Karo Pharma Aktiebolag announces that the acquisition of the European OTC brand portfolio from Teva Pharmaceuticals (Tev...

April 6, 2021 | Tuesday | News
Daiichi Sankyo starts Ph 1 Trial for Nafamostat Inhalation Formulation to treat COVID-19

Daiichi Sankyo, based in Japan, has announced that it has initiated in Japan a first-in-human phase 1 trial for nafamost...

April 5, 2021 | Monday | News
Daiichi Sankyo incurs 15 B yen loss after terminating vaccine biz with Sanofi

Daiichi Sankyo Company, Ltd. has announced that it will terminate its marketing alliance agreement for the Squarekids&re...

April 1, 2021 | Thursday | News
KYORIN, Eisai to develop & market drug for overactive bladder treatment in 4 ASEAN countries

Japanese firms KYORIN Pharmaceutical, a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a lic...

March 31, 2021 | Wednesday | News
Autonomous buildings key to driving pharmaceutical advancements

With COVID-19 accelerating the digital economy and the shift to Industry 4.0, how can pharmaceutical companies drive fur...

April 7, 2021 | Wednesday | News
Samsung Bioepis continues global market expansion

Biopharmaceutical firm Samsung Bioepis, based in South Korea, has announced its expansion of its global footprint to Aus...

March 30, 2021 | Tuesday | News
Hutchmed divests non-core OTC joint venture for $169 M

Hutchison China MediTech Limited (HUTCHMED) has announced that it has reached an agreement with GL Mountrose Investment ...

March 29, 2021 | Monday | News
Foresee Pharma Initiates Ph 2/3 trial for COVID-19 associated ARDS treatment

Taiwan based Foresee Pharmaceuticals Co., Ltd., has announced the initiation of patient dosing in the Phase 2/3 clinical...

March 29, 2021 | Monday | News